Compare Aegon Ltd. (AEG) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Aegon Ltd. vs Twist Bioscience Corp — how do they compare? Aegon Ltd. trades at $9.44 (market cap $14.01B), while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: Aegon Ltd. is the larger of the two by market cap, and Aegon Ltd. pays a 4.94% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| AEG | TWST | |
|---|---|---|
Market Cap | $14.01B | $7.72B |
Sector | Financials | Health |
52-Week High | $9.53 | $124.88 |
52-Week Low | $6.79 | $24.16 |
Enterprise Value | $15.16B | $7.65B |
Dividend Yield | 4.94% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Aegon Ltd.
Aegon is a Netherlands-headquartered insurance company with core operations that stretch across the U.S., Netherlands, and United Kingdom. The business also holds peripheral ventures in Spain, Portugal, Brazil, and China.
Read more on AEG →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
